Daily Stock Analysis, ELGX, Endologix Inc, priceseries

Endologix Inc. Daily Stock Analysis
Stock Information
Open
2.87
Close
2.88
High
2.90
Low
2.81
Previous Close
2.86
Daily Price Gain
0.02
YTD High
8.94
YTD High Date
Jan 18, 2019
YTD Low
2.28
YTD Low Date
Oct 30, 2019
YTD Price Change
-4.52
YTD Gain
-61.08%
52 Week High
10.36
52 Week High Date
Nov 19, 2018
52 Week Low
2.28
52 Week Low Date
Oct 30, 2019
52 Week Price Change
-7.32
52 Week Gain
-71.76%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 27. 2017
44.00
Oct 10. 2017
52.67
9 Trading Days
19.69%
Link
LONG
May 9. 2018
45.50
Jun 19. 2018
61.24
28 Trading Days
34.59%
Link
LONG
Mar 11. 2019
6.05
Mar 22. 2019
6.87
9 Trading Days
13.51%
Link
LONG
Jun 6. 2019
6.92
Jun 21. 2019
7.44
11 Trading Days
7.55%
Link
Company Information
Stock Symbol
ELGX
Exchange
NasdaqGS
Company URL
http://www.endologix.com
Company Phone
9495957200
CEO
John D. McDermott
Headquarters
California
Business Address
2 MUSICK, IRVINE, CA 92618
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001013606
About

Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, VELA Proximal Endograft, Intuitrak Endovascular AAA System, and Nellix Endovascular Aneurysm Sealing System. The company was founded in March 1992 and is headquartered in Irvine, CA.

Description

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. It offers minimally-invasive endovascular repair (EVAR) products, including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the ovation abdominal stent graft system. The company also provides endovascular sealing (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, it offers proximal aortic extensions and limb extensions, which attach to the main body of its EVAR device, allowing physicians to customize it to fit the patient's anatomy; and accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, inflation devices, and snares. The company offers its EVAR products under Powerlink System, IntuiTrak, AFX, VELA Proximal Endograft brand names; and EVAS products under the Nellix EVAS system brand name. It sells its products through direct sales force, network of agents, and independent distributors or agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.